This trial is testing a new way to help people with Alcohol Use Disorder (AUD), by trying to find biomarkers that show if a person will respond to a medication called acamprosate.
0 Primary · 1 Secondary · Reporting Duration: The number of days until first alcohol use assessed by TLFB during 3 months of treatment
800 Total Participants · 2 Treatment Groups
Primary Treatment: Acamprosate · Has Placebo Group · Phase 4
Age 18+ · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: